1/492
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Intra-brand Competition
Competition among sellers of the same brand.
Inter-brand Competition
Competition between different brands in the market.
Proportionality Principle
Restrictions must be necessary and proportionate to objectives.
Market Exclusion
Preventing a competitor from accessing a market.
Litmus Test for Competition
Criteria to evaluate if competition is restricted. The litmus test for establishing a restriction of competition in this case looks at whether the restrictions were objectively necessary and examines whether the agreements:
- Contribute to improving the distribution of goods,
- Allow consumers to benefit fairly,
- Avoid imposing unnecessary restrictions, and
- Do not eliminate competition for a substantial part of the products concerned
Dual Pricing Scheme
Different prices for domestic and export pharmaceuticals.
Parallel Trade
Cross-border trade of goods within EU Member States.
Restrictions by Object
Certain harmful practices presumed anti-competitive without proof.
Horizontal Price-Fixing Cartels
Coordination types harmful enough to restrict competition.
Restriction of Competition by Object
Agreement inherently harms competition without effects analysis.
Sufficient Degree of Harm
Necessary for classifying restriction by object.
Referral Back to General Court
CJEU's instruction for further evaluation of effects.
Restrictive Practices
Actions that limit competition or market entry.
Competitive Harm
Evidence of negative impact on market competition.
Cartes Bancaires
Case highlighting risks of anti-competitive schemes.
Market Power
Ability of a company to influence market conditions.
Dominant Position
Significant control over market dynamics by a company.
Market Share
Percentage of total sales controlled by a company.
Competition Threat
Inability of competitors to effectively challenge dominance.
Customer Power
Customers' ability to influence market dynamics.
Anticompetitive Foreclosure
Blocking competitors harms consumers' market options.
Price-Based Exclusionary Conduct
Using unfair pricing to eliminate competition.
Below-Cost Pricing
Selling below production cost to harm rivals.
Cost Measures
Data used to evaluate competitor survival under pricing.
Justifications for Conduct
Defenses for dominant companies' potentially harmful actions.
Exclusive Dealing
Requiring customers to purchase exclusively from one supplier.
Conditional Rebates
Discounts based on meeting specific purchasing criteria.
Efficiencies
Benefits that must outweigh competition harm in assessments.
Tying
Mandatory purchase of a secondary product with a main one.
Bundling
Selling multiple products together at a discounted price.
Market Conditions
Factors affecting competition, including entry barriers.
Customer Behavior
Actions and preferences of customers influencing market dynamics.
Supplier Influence
Impact of suppliers on market competition and pricing.
Harmful Conduct Duration
Length of time the anti-competitive behavior persists.
Intent to Harm Competition
Evidence showing deliberate actions against market rivals.
Multi-Product Rebates
Discounts on bundles affecting competitor profits.
Commission Role
Evaluates competitor profitability against bundled discounts.
Efficiencies
Cost reductions benefiting consumers without harming competitors.
Predation
Dominant firms incur losses to eliminate competition.
Sacrifice
Selling below production cost indicates intentional losses.
Average Avoidable Cost (AAC)
Minimum price to avoid losses in production.
Anti-competitive Foreclosure
Actions preventing efficient competitors from competing.
Market Manipulation
Strategies to deter new or existing competitors.
Refusal to Supply
Dominant firms denying essential products raises concerns.
Margin Squeeze
Pricing prevents competitors from making a profit.
Litmus Test
Criteria for evaluating market dominance and conduct.
Market Dominance
Company's strength and control in the market.
Barriers to Entry
Obstacles preventing new competitors from entering.
Competitor Status
Importance of even small competitors in analysis.
Customer Behavior
Consumer responses to company actions matter.
Supplier Behavior
Supplier dynamics influence competitive landscape.
Harmful Conduct Duration
Length and spread of anti-competitive behavior.
Intent to Harm
Evidence of a company's motive to reduce competition.
Price-Based Exclusionary Conduct
Pricing strategies aimed at excluding competitors.
Justifications for Behavior
Possible reasons for a company's anti-competitive actions.
Error Costs
Risks of misclassifying competitive practices as anti-competitive.
Over-Enforcement
False positives leading to unnecessary penalties.
Under-Enforcement
False negatives allowing harmful practices to persist.
Competition Law
Regulations promoting market fairness and innovation.
SCP Thinking
Framework analyzing Structure, Conduct, Performance.
Market Structure
Composition and organization of firms in a market.
Market Conduct
Behavior of firms in the marketplace.
Market Performance
Efficiency and effectiveness of market outcomes.
101 TFEU
Prohibits cooperation restricting competition.
102 TFEU
Prohibits abuse of dominant market position.
Merger Control
Regulation requiring approval for significant mergers.
Internal Market
EU market ensuring free movement of goods.
Undistorted Competition
Fair competition without barriers between member states.
Article 26(2) TFEU
Guarantees free movement within the internal market.
Protocol No. 27
Supports competition rules for internal market creation.
Price Fixing
Agreement among firms to set prices collectively.
Reverse Engineering
Analyzing laws to identify underlying objectives.
Error Costs
Costs associated with incorrect legal interpretations.
Accused Undertaking
Entity being investigated for competition law violations.
Commission
EU body enforcing competition law through complaints.
Plaintiff
Party initiating a complaint in competition cases.
Article 102 Objectives
Sanctions practices harming competition structure or consumers.
Intel Case
Illustrates permissible aggressive competition behavior.
Consumer Healthcare
Focus on consumer welfare in competition assessments.
Competitively Restrictive Behavior
Actions limiting competition, potentially justified by benefits.
Structure-Tree Analysis
Examining market structure to assess competition restrictions.
Competitive Process
Interaction between firms affecting market dynamics.
Market Structure
Organization of a market based on competition levels.
Efficiency
Performance outcome of the competitive process.
Selective Distribution
Restricts distributors to enhance market power.
Metro I Case
Case illustrating compliance with distribution criteria.
GlaxoSmithKline Case
Examines pharmaceutical monopolies and pricing strategies.
Consumer Welfare
Benefits received by consumers from market competition.
Monopoly
Single seller dominating a market, potentially beneficial.
Trade-off in Welfare
Balancing current and future consumer benefits.
Cartes Bancaires Case
High prices in digital payments due to market structure.
Commission Guidance
Advice for proving efficiency in competition complaints.
Efficient Competitor
Firm capable of competing effectively in the market.
EU Competition Law
Regulations governing competition within the European Union.
Innovation Focus
Emphasis on developing new products and technologies.
Pharmaceutical Patents
Government grants protecting drug manufacturers' innovations.
Market Monopoly
Dominance by a single firm, often due to patents.
Competition Health
Assessment of market dynamics and firm performance.
Digital Payment Market
Sector involving electronic transactions and payment systems.
Market Integrity
Overall stability and fairness of the market structure.